Toronto, Ontario--(Newsfile Corp. - February 4, 2021) - Leveljump Healthcare Corp. (TSXV: JUMP) ("Leveljump" or the "Company"), a Canadian leader in B2B telehealth solutions, is pleased to announce that the Company has applied to the TSX Venture Exchange (the "TSXV") for listing 10,757,622 common share purchase warrants.

A total of 10,757,622 subscription receipts units were issued pursuant to the Company's brokered private placements which closed on October 30, 2020 and November 25, 2020. The Financings were completed in conjunction with the Qualifying Transaction in which the Company's common shares were listed on the TSXV. Each unit is comprised of one common share of Leveljump and one share purchase warrant. Each share purchase warrant entitles the holder thereof to acquire one common share of the Company at an exercise price of C$0.50 until October 30, 2023.

The Warrants are governed by a warrant indenture between the Company and TSX Trust Company dated October 30, 2020, a copy of which is available under the Company's profile at .

About Leveljump Healthcare

Leveljump Healthcare Corp., (TSXV: JUMP) is building a national medical diagnostic imaging company and brand, primarily by providing teleradiology (remote radiology) services to its client hospitals and imaging centers. Additionally, JUMP plans to expand through the acquisition of independent healthcare facilities focused on diagnostic imaging as well as acquiring new disruptive imaging technologies.

ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.

Mitchell Geisler, Chief Executive Officer

(877) 722-6965

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.

To view the source version of this press release, please visit